The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement

Clinical trial NCT04573049 · UNKNOWN

Trial details

NCT number: NCT04573049
Sponsor: China National Center for Cardiovascular Diseases
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Aortic Valve Stenosis Heart Failure Inotropic Agents Safety Issues Effect of Drug Cardiac Event Transcatheter Aortic Valve Replacement

Start date: 2020-09-01
Primary completion: 2022-04-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.